The absence of nuclear PHD2 and PHD3 expression in ccRCC was associated with poor RFS and the nuclear expression of PHD2 predicted RFS regardless of other known histopathological prognostic factors. The gene discussed is EGLN3; the disease is nonpapillary renal cell carcinoma.